University of Chicago Medical Center

Medical research

Team describes step-by-step progress in battling toxoplasmosis

In the July 14 edition of Scientific Reports, 39 researchers from 14 leading institutions in the United States, United Kingdom and France suggest novel approaches that could hasten the development of better medications for ...

Oncology & Cancer

For women with genetic risk, bi-annual MRI beats mammograms

Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than ...

Oncology & Cancer

Beehive extract shows potential as prostate cancer treatment

An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine.

Psychology & Psychiatry

A potential new class of fast-acting antidepressant

More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered ...

Neuroscience

Sense of touch reproduced through prosthetic hand

In a study recently published in IEEE Transactions on Neural Systems and Rehabilitation Engineering, neurobiologists at the University of Chicago show how an organism can sense a tactile stimulus, in real time, through an ...

Sleep disorders

Surgery for sleep apnea improves asthma control

Surgical removal of the tonsils and adenoids in children suffering from sleep apnea is associated with decreased asthma severity, according to the first large study of the connection, published in the journal PLOS Medicine.

Medical research

Year-long survey tracks the microbiome of a newly opened hospital

A 12-month study mapping bacterial diversity within a hospital—with a focus on the flow of microbes between patients, staff and surfaces—should help hospitals worldwide better understand how to encourage beneficial microbial ...

Oncology & Cancer

Pembrolizumab shows real promise against head and neck cancer

Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American ...

page 12 from 38